Elevated expression levels of NFKB2 and the activation of the alternative pathway of NF‐κB have been confirmed in non‐small cell lung cancer, breast cancer, prostate tumors, and several cancer cell lines.12, 13, 14, 15. Here, NFKB1 is linked to cancer.